ArticleArchives of toxicology2026
Developmental neurotoxicity of atrazine: decreased synaptic spine density and miRNA-driven GluN2A downregulation in primary hippocampal neurons.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrazine (ATZ) is a triazine herbicide and a persistent environmental contaminant. Its use is associated with effects on the nervous system in experimental models. Behavioral and molecular alterations have been reported after exposure, but the cellular mechanisms underlying atrazine-induced developmental neurotoxicity remain unclear, particularly at the synaptic level. In this study, we investigated the effects of ATZ exposure on glutamatergic synaptic maturation in rat primary hippocampal neurons. Neuronal cultures were exposed to ATZ throughout the in vitro developmental period, and structural and molecular endpoints were assessed. Dendritic spines were analyzed by confocal microscopy, and the expression of glutamatergic receptor subunits was evaluated by Western blot and RT-qPCR. In parallel, microRNA expression profiles targeting NMDA receptor subunits were examined to explore post-transcriptional regulatory mechanisms. ATZ exposure induced a selective reduction in dendritic spine density, without detectable changes in spine morphology. This structural effect was accompanied by a selective decrease in the NMDA receptor subunit GluN2A at both protein and mRNA levels, while GluN1, GluN2B, and AMPA receptor subunits were unaffected. Notably, GluN2A downregulation was preceded by the upregulation of microRNAs predicted to target the GRIN2A transcript, indicating a microRNA-mediated regulatory mechanism. Overall, these results demonstrate that ATZ can interfere with hippocampal synaptic maturation by selectively modulating NMDA receptor subunit composition through epigenetic mechanisms. This study identifies dendritic spine and GluN2A regulation as sensitive endpoints of ATZ-induced developmental neurotoxicity and provides mechanistic insight into how early synaptic processes may be affected by this herbicide.
Indexed as
Identifiers
42446668What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.